Art. 1 Decision_act (EU) 2000/77

In forcesince 17 Dec 1999
1.

The Community shall purchase as soon as possible the following strains of foot-and-mouth disease antigen:

–

A Iran 96: 1000000 doses,

–

A Iran 99: 1000000 doses,

–

A Malaysia 97: 500000 doses,

–

SAT1: 500000 doses,

–

SAT2 (Southern Africa): 500000 doses,

–

SAT2 (East Africa): 500000 doses,

–

SAT3: 500000 doses.

2.

The Community shall make arrangements for formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens referred to in paragraph 1.

3.

The maximum cost of the measures referred to in paragraphs 1 and 2 shall be up to EUR 2,5 million.

4.

The action referred to in paragraph 3 shall be organised by the Commission before 31 December 1999.